Drug Profile
Research programme: follicle-stimulating hormone agonists oral - TocopheRx
Alternative Names: FSH agonist - TocopheRxLatest Information Update: 28 Jul 2018
Price :
$50
*
At a glance
- Originator EMD Serono
- Developer TocopheRx
- Class
- Mechanism of Action Follicle stimulating hormone stimulants; Ovarian follicle stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Female infertility; Male infertility
Most Recent Events
- 28 Jul 2018 No recent reports of development identified for preclinical development in Female-infertility in USA (PO)
- 28 Jul 2018 No recent reports of development identified for preclinical development in Male-infertility in USA (PO)
- 02 Dec 2013 EMD Serono forms spin-off company TocopheRx for further development of its infertility programme in USA